Tumour tissue transport after intraperitoneal anticancer drug delivery

被引：27

作者：

Carlier, Charlotte ^{[1
]}

Mathys, Ada ^{[1
]}

De Jaeghere, Emiel ^{[2
]}

Steuperaert, Margo ^{[3
]}

De Wever, Olivier ^{[2
,4
]}

Ceelen, Wim ^{[1
,4
]}

机构：

[1] Univ Ghent, Dept Surg, Expt Surg Lab, Ghent, Belgium

[2] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium

[3] Univ Ghent, Biofluid Tissue & Solid Mech Med Applicat bioMMed, Dept Elect & Informat Syst, iMinds Med IT Dept, Ghent, Belgium

[4] Univ Ghent, CRIG, Ghent, Belgium

来源：

INTERNATIONAL JOURNAL OF HYPERTHERMIA | 2017年 / 33卷 / 05期

关键词：

Intraperitoneal; carcinomatosis; drug delivery; pharmacokinetics; INTERSTITIAL FLUID PRESSURE; INTENSITY FOCUSED ULTRASOUND; AEROSOL CHEMOTHERAPY PIPAC; PANCREATIC DUCTAL ADENOCARCINOMA; HUMAN OSTEOSARCOMA XENOGRAFTS; HEDGEHOG PATHWAY INHIBITOR; PERITONEAL CARCINOMATOSIS; OVARIAN-CANCER; IN-VIVO; SOLID TUMORS;

D O I：

10.1080/02656736.2017.1312563

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Intraperitoneal (IP) drug delivery, either as an intraoperative chemoperfusion or as an adjuvant, repeated instillation, is an established treatment modality in patients with peritoneal carcinomatosis. The efficacy of IP drugs depends on its ability to penetrate the tumour stroma in order to reach their (sub)cellular target. It is known, that drug penetration after IP delivery is limited to a few millimetres. Here, we review the basic tissue transport mechanisms after IP delivery and discuss the biophysical barriers and obstacles that limit penetration distance. In addition, we review the physical and pharmaceutical interventions that have been studied in order to improve delivery of small molecular and macromolecular drugs after IP instillation. These interventions could inform the design of future clinical trials aiming at an improved efficacy of IP-based drug delivery in carcinomatosis patients.

引用

页码：534 / 542

页数：9

共 92 条

[71] Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy [J].

Sherman, Mara H. ;

Yu, Ruth T. ;

Engle, Dannielle D. ;

Ding, Ning ;

Atkins, Annette R. ;

Tiriac, Herve ;

Collisson, Eric A. ;

Connor, Frances ;

Van Dyke, Terry ;

Kozlov, Serguei ;

Martin, Philip ;

Tseng, Tiffany W. ;

Dawson, David W. ;

Donahue, Timothy R. ;

Masamune, Atsushi ;

Shimosegawa, Tooru ;

Apte, Minoti V. ;

Wilson, Jeremy S. ;

Ng, Beverly ;

Lau, Sue Lynn ;

Gunton, Jenny E. ;

Wahl, Geoffrey M. ;

Hunter, Tony ;

Drebin, Jeffrey A. ;

O'Dwyer, Peter J. ;

Liddle, Christopher ;

Tuveson, David A. ;

Downes, Michael ;

Evans, Ronald M. .

CELL, 2014, 159 (01) :80-93

[72] iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes [J].

Simon-Gracia, Lorena ;

Hunt, Hedi ;

Scodeller, Pablo ;

Gaitzsch, Jens ;

Kotamraju, Venkata Ramana ;

Sugahara, Kazuki N. ;

Tammik, Olav ;

Ruoslahti, Erkki ;

Battaglia, Giuseppe ;

Teesalu, Tambet .

BIOMATERIALS, 2016, 104 :247-257

[73] Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors [J].

Skliarenko, JV ;

Lunt, SJ ;

Gordon, ML ;

Vitkin, A ;

Milosevic, M ;

Hill, RP .

CANCER RESEARCH, 2006, 66 (04) :2074-2080

[74] Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy [J].

Solass, Wiebke ;

Kerb, Reinhold ;

Muerdter, Thomas ;

Giger-Pabst, Urs ;

Strumberg, Dirk ;

Tempfer, Clemens ;

Zieren, Juergen ;

Schwab, Matthias ;

Reymond, Marc Andre .

ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) :553-559

[75] Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects [J].

Solass, Wiebke ;

Giger-Pabst, Urs ;

Zieren, Juergen ;

Reymond, Marc A. .

ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) :3504-3511

[76]

Steuperaert M, PLEURA PERI IN PRESS

[77] A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis [J].

Sugahara, Kazuki N. ;

Scodeller, Pablo ;

Braun, Gary B. ;

de Mendoza, Tatiana Hurtado ;

Yamazaki, Chisato M. ;

Kluger, Michael D. ;

Kitayama, Joji ;

Alvarez, Edwin ;

Howell, Stephen B. ;

Teesalu, Tambet ;

Ruoslahti, Erkki ;

Lowy, AndrewM. .

JOURNAL OF CONTROLLED RELEASE, 2015, 212 :59-69

[78] Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs [J].

Sugahara, Kazuki N. ;

Teesalu, Tambet ;

Karmali, Priya Prakash ;

Kotamraju, Venkata Ramana ;

Agemy, Lilach ;

Greenwald, Daniel R. ;

Ruoslahti, Erkki .

SCIENCE, 2010, 328 (5981) :1031-1035

[79] Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors [J].

Sugahara, Kazuki N. ;

Teesalu, Tambet ;

Karmali, Priya Prakash ;

Kotamraju, Venkata Ramana ;

Agemy, Lilach ;

Girard, Olivier M. ;

Hanahan, Douglas ;

Mattrey, Robert F. ;

Ruoslahti, Erkki .

CANCER CELL, 2009, 16 (06) :510-520

[80] Integrin-mediated mechanotransduction [J].

Sun, Zhiqi ;

Guo, Shengzhen S. ;

Fassler, Reinhard .

JOURNAL OF CELL BIOLOGY, 2016, 215 (04) :445-456

← 1 2 3 4 5 6 7 8 9 10 →